In addition, the role of NOX4 in NASH–HCC transition remains controversial, since opposite results regarding the expression and activity of NOX4 in HCC development and patients’ survival have been reported in different studies. The gene discussed is NOX4; the disease is metabolic dysfunction-associated steatohepatitis.